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Background: Two healthcare innovations were successfully implemented using different implementation strategies.
First, a Short Stay Programme for breast cancer surgery (MaDO) was implemented in four early adopter hospitals,
using a hospital-tailored implementation strategy. Second, the Enhanced Recovery After Surgery (ERAS) programme
for colonic surgery was implemented in 33 Dutch hospitals, using a generic breakthrough implementation strategy.
Both strategies resulted in a shorter hospital length of stay without a decrease in quality of care. Currently, it is
unclear to what extent these innovative programmes and their results have been sustained three to five years
following implementation. The aim of the sustainability of healthcare innovations (SUSHI) study is to analyse
sustainability and its determinants using two implementation cases.
Methods: This observational study uses a mixed methods approach. The study will be performed in 14 hospitals in
the Netherlands, from November 2010. For both implementation cases, the programme aspects and the effects will
be evaluated by means of a follow-up measurement in 160 patients who underwent breast cancer surgery and 300
patients who underwent colonic surgery. A policy cost-effectiveness analysis from a societal perspective will be
performed prospectively for the Short Stay Programme for breast cancer surgery in 160 patients. To study
determinants of sustainability key professionals in the multidisciplinary care processes and implementation change
agents will be interviewed using semi-structured interviews.
Discussion: The concept of sustainability is not commonly studied in implementation science. The SUSHI study will
provide insight in to what extent the short-term implementation benefits have been maintained and in the
determinants of long-term continuation of programme activities.Background
Quality improvement strategies are used to change and
improve healthcare. However, often healthcare innova-
tions barely get incorporated in every day practice [1-4].
Implementing an innovation is a complex process. Studies
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reproduction in any medium, provided the oraccording to evidence-based knowledge and 20-25% of
the healthcare provided is not needed or potentially harm-
ful [5-7]. There is a high level of agreement between all
parties involved in healthcare that the quality of care could
be improved. Currently, there is no consensus on how to
achieve better care. A diversity of quality improvement
strategies to change and improve healthcare routines has
been proposed. However, there is not one strategy that is
superior in its effect above other strategies in improving
healthcare processes [7]. Although magic bullets are lac-
king among the prevailing implementation strategies, evi-
dence suggests that implementation strategies which are
systematically tailored to the actual and perceived barriers
and facilitators for change increase the success of imple-
mentation [8,9].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mentation strategies. Even after successful implementa-
tion, practice seems to indicate that there is a tendency
to return to old routines after implementation activities
have ended. It can be argued that without consolidation
of the achieved benefits, implementation strategies are a
waste of time and money. Implementation strategies’
‘good value for money’ is determined by its ability to im-
plement evidence based clinical guidelines into daily
routines and by the implementation costs [10]. The im-
plication of discontinued programmes is however not
just financial but can also result in less optimal care and
service for patients. Moreover, it can also diminish com-
munity trust and support for future programmes. There-
fore, it is important that achieved benefits of a proven
effective intervention are sustained after implementation.
Sustainability is a relatively new term in healthcare re-
search, but has become an issue of growing interest.
There is no uniform definition of sustainability in the
literature [11]. In its simplest form, it can be seen as
‘holding the gains’ and ‘evolving as required’. Different
definitions regarding sustainability are used, for example
“maintaining the health benefits [12]”, “continuation of
the programme activities within an organisational struc-
ture [13]” and “building the capacity of a recipient com-
munity [14]” [11,15,16]. Sustainability is generally seen
as a dynamic process of continuous improvement. In the
current study we use the following definition: “Sustai-
nability of change exists when a newly implemented in-
novation continues to deliver the achieved benefits over a
longer period of time, certainly does not return to the
usual processes and becomes ‘the way things are done
around here’, until a better innovation comes along, even
after the implementation project is no longer actively car-
ried out [11,17]”
Sustainability is obtaining its position in healthcare re-
search, but existing work on sustainability has mainly
been undertaken from a pragmatic perspective and was
impoverished by a lack of process information [18]. Se-
veral determinants can have a facilitating or impeding
effect on sustainability. Important questions that still
need to be answered are by what strategies particular
healthcare innovations are implemented and sustainedTable 1 Overview implementation cases
MaDO
No of participating hospitals 4
Innovation Ultra Short stay programme afte
Implementation strategy Hospital tailored strategy
Implementation time span 2005 – 2007
Measurement periods Two measurement periods of six
of actual implementation in betw(or not) in particular contexts and settings, and whether
these strategies can be improved.
Few empirical studies have specifically addressed the
implementation and sustainability of innovations. In
the current study two Dutch implementation cases are
used for research on sustainability and its determinants
(Additional file 1 and Additional file 2). A Short Stay
Programme (MaDO) was implemented in breast cancer
surgery in 4 early adopter hospitals by means of a hos-
pital tailored implementation strategy [19-22], and the
Enhanced Recovery After Surgery (ERAS) programme
in colonic surgery was implemented in 33 hospitals by
means of a generic implementation strategy [23,24]. As
a result of these efforts (Table 1), both cases showed
improved short-term results in terms of hospital length
of stay. However, it is currently unknown to what ex-
tent and how these programmes and their results have
been sustained.
Objectives
In the present study we will assess sustainability of a
Short Stay Programme in breast cancer surgery and the
Enhanced Recovery After Surgery programme in colonic
surgery, three to five years after their implementation.
The research questions are:
1. To what extent have the achieved benefits of the
Short Stay Programme in breast cancer surgery and
the Enhanced Recovery After Surgery programme in
colonic surgery been sustained?
2. What is the current policy cost-effectiveness of the
Short Stay Programme in breast cancer surgery?
3. Which are the determinants of sustainability as
perceived by the professionals of the Short Stay
Programme in breast cancer surgery and the




The present study is an observational study using a
mixed methods approach, applied to the two implemen-
tation cases. First, by means of a retrospective analysis ofERAS
33
r breast cancer surgery ERAS programme in colonic surgery
The Breakthrough Series
2006 – 2009
months, with six months
een
Three runs of each one year
Table 2 Outcome indicators and baseline characteristics
scored in both cases
MaDO ERAS
Primary outcome Primary outcome
Treated surgically in day care Postoperative hospital length
of stay
Treated surgically in overnight stay Day functional recovery
was reached
Baseline characteristics Baseline characteristics
Patient characteristics Patients characteristics
Eligible for surgery in short stay Laparoscopic or open approach
Receiving breast conserving surgery Different types of operations
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care to assess the extent of sustainability. Second, the
policy cost-effectiveness will be calculated for the Short
Stay Programme based on prospective data from breast
cancer surgery patients. The cost-effectiveness analysis
will use the same methodology as in the primary im-
plementation study [19]. Third, the determinants of
sustainability will be explored by means of in-depth
semi-structured interviews with relevant stakeholders
and external change agents. This study will be executed
between November 2010 and November 2013.
Ethical approval and informed consent
The Medical Ethical Committee of the University of
Maastricht has granted approval, METC 11-4-015.10.
The privacy of the included patients is protected, and all
data will be coded and processed anonymously. Medical
files with explicit patient statements that their medical
information should not be used for clinical research will
not be included. Breast cancer patients eligible for the
second research question in this study will be asked for
informed consent for prospective collection of quality of
life and cost data.
Participants
Hospitals
Hospitals participating in the breast cancer surgery case
are those four hospitals which participated in the pri-
mary implementation strategy, covering four main or-
ganisational hospital settings in the Netherlands. The
uptake of the Short Stay Programme in breast cancer
surgery was successful in all four hospitals; after imple-
mentation the average proportion of patients treated in
short stay was increased with 36%.
Hospitals participating in the colonic surgery case were
selected out of the 33 hospitals which participated in the
primary implementation strategy. Selection was based on
the criterion that the implementation strategy was suc-
cessfully executed in these hospitals, such that the chance
of finding information on sustainability and its determi-
nants is increased. Success was defined as follows: (1) a
median hospital length of stay of six days or lower, (2) an
overall protocol compliance above seventy percent, and
(3) at least forty patients treated according to the ERAS
programme. Ten hospitals were selected for the SUSHI
study. Nine hospitals fulfilled the criteria and one hospital
was selected on top of that, based on being a successful
early adopter hospital.
Research question one: To what extent have the
achieved benefits of the Short Stay Programme in
breast cancer surgery and the Enhanced Recovery
After Surgery programme in colonic surgery been
sustained?Participants
Patients
Data collection will be conducted among the last 160
consecutive patients who had been scheduled for breast
cancer surgery in short stay (40 per centre) and the last
300 consecutive patients who underwent colonic surgery
(30 per centre), who met the same inclusion criteria as
in the primary implementation studies. Patients in the
breast cancer surgery case are all patients aged over
18 years, diagnosed with breast cancer, and who under-
went surgery. Patients whose physiology at diagnosis im-
peded participation in the short stay programme as
assessed by the breast surgeon, anaesthesiologist and
nurse, will be excluded from the study. Patients who could
not rely on sufficient informal home care during the first
night after surgery and patients with complaints that
necessitated postoperative monitoring and were scheduled
for at least one overnight stay, will also be excluded.
Patients included in the colonic surgery case were all
patients aged over 18 undergoing an elective colonic re-
section above the peritoneal reflection for both malignant
and benign diseases. Patients undergoing emergency sur-
gery and requiring an ileo- or colostomy are excluded.
Variables and measurements
Outcome and process of care will be measured by means
of pre-defined indicators to determine the extent of sus-
tainability of both programmes, which will be extracted
from patient files. The primary outcome measure in the
breast cancer surgery case is the proportion of breast
cancer surgery patients treated in day care admission or
one overnight stay. Secondary outcome measure is the
number of complications. The primary outcome mea-
sure in the colonic surgery case is the hospital length of
stay (LOS). Secondary outcome measure is Functional
Recovery (FR), reached when a patient is tolerating solid
foods, is comfortable on oral analgesics only, and mobi-
lised at preoperative level [25]. Baseline patient charac-
teristics and possible reasons for delay in discharge (the
gap between FR and LOS) will be recorded (Table 2).
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the breast cancer surgery and colonic surgery case, the
outcome measure is the adherence to the protocol. Ad-
herence to the protocol will be determined per process
indicator and per patient. Reasons for non-adherence to
specific guideline elements will be recorded if available.
Data analysis
Descriptive statistics (proportions, mean, median) will be
performed for both outcome data sets. The percentage
adherence to the protocol will be calculated per pro-
gramme element for both cases and an overall proto-
col adherence score will be calculated per patient. All
statistical analyses will be performed using SPSS 18.0
(SPSS Inc. Chicago, Illinois, USA).
Research question two: What is the current policy
cost-effectiveness of the Short Stay Programme in
breast cancer surgery?
Participants
In this prospective part of the study 40 consecutive
patients operated per centre (n = 160 (4 × 40)) will be
included. Again we will use the same inclusion and ex-
clusion criteria as in the primary implementation study.
Variables and measurements
Policy cost analysis
The cost analysis will be performed from a societal per-
spective, using the Dutch guidelines for cost calculationsTable 3 Process indicators in both cases
MaDO
Preoperative counselling
Not planned for short stay admission despite fulfilling the inclusion
criteria for short stay admission
Being offered home care nursing after breast cancer surgery
The reasons for discrepancy between fulfilling the inclusion criteria for
short stay admission and being scheduled for inpatient admission
The reasons for not being treated in short stay despite being scheduled
for short stayin healthcare [26]. Policy costs represent both the pro-
gramme and implementation costs [27]. The Short Stay
Programme in breast cancer surgery related direct and
indirect healthcare and non-healthcare costs will be mea-
sured and valued. We will use a bottom up micro costing
method which identifies and measures the healthcare pro-
ducts per patient [26]. Costs will be expressed in 2012
Euros. Direct healthcare related resource use will be
obtained using Case Record Forms. Direct costs outside
healthcare and out of pockets costs will be collected
through a cost diary filled out by patients. One day before
surgery, patients will fill out the retrospective part of the
cost book to determine the healthcare related costs for a
period of two weeks before surgery. Patients will fill out
the prospective part of the cost book during six weeks
from the moment of discharge. This time horizon will
cover most costs related to surgical treatment and is also
used in the primary implementation study. To perform the
cost calculations, the volumes of (healthcare) resource use
are multiplied with the cost prices per unit of resource use.
Cost prices from the primary study will be actualised and
used in this study. Indirect costs are the productivity losses
due to sick leave; these will be calculated using the friction
costs method. A friction cost method confines productivity
losses to the period needed to replace a sick worker.
Historical implementation costs of the Short Stay
Programme in breast cancer surgery will be used in
this study, as these costs have been made in the pri-
mary implementation study. The implementation costs
were assessed as mean costs per patient.ERAS
Preoperative counselling
No preoperative bowel preparation
Preoperative PreOp carbohydrate drink
Epidural anaesthesia/analgesia
Perioperative warming (Bair hugger)
No abdominal drains placed during surgery
Nasogastric tube removed after surgery
Nutritional supplements postoperatively
Mobilisation > 15 minutes at day 0
Use of oral fluids >500 ml at day 0
Mobilisation > 3 hours at day 1
Intravenous fluid infusion stopped at day
Resumption of solid food at day 1
Removal of epidural analgesia on day 2
Oral laxatives postoperatively
The reasons for not adhering to these different protocol elements
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Effectiveness will be determined through a generic health-
related quality of life (HRQoL) instrument. In this study
the EuroQol (EQ-5D) will be used to calculate quality-
adjusted life years (QALYs) [28]. The EQ-5D consists of
five different dimensions (mobility, self-care, daily acti-
vities, pain/discomfort, depression/anxiety). Every dimen-
sion has three answer possibilities (no problems, some
problems, severe problems), which can lead to 243 diffe-
rent health states. The health states as measured in this
study will be used for utility score calculation, based on
the UK tariff. The utility scores will be determined at four
consecutive time points: one day before first surgery (at
baseline), one day after first surgery, one week after first
surgery and six weeks after first surgery.
Data analyses
In this study the current incremental cost-effectiveness
ratio (ICER) will be calculated for the Short Stay Pro-
gramme in breast cancer surgery versus care as usual
before primary implementation. For calculation of the
ICER, mean incremental policy costs will be divided by
the mean incremental QALYs. Multiple imputations will
be used to replace missing values with plausible esti-
mates. Bootstrapping will be performed to determine
95% confidence intervals around cost differences bet-
ween the Short Stay Programme in breast cancer surgery
and care as usual. Bootstrapping will also be used to
quantify the uncertainty around the ICER and will be
performed using Excel 2003 [29]. The results will be pre-
sented in an incremental cost-effectiveness plane in
which the vertical axis will represent the incremental
effects and the horizontal axis will show the incremen-
tal costs between the Short Stay Programme and care
as usual before implementation. This will result in four
quadrants: 1) southeast quadrant (SE) 2) northwest qua-
drant (NW) 3) southwest quadrant (SW) 4) northeast
quadrant (NE). The cost-effectiveness acceptability curve
will be calculated to present the probability of the
Short Stay Programme being cost-effective for a range
of ceiling ratios using Excel 2003. These analyses will
be performed using SPSS 18.0 (SPSS Inc. Chicago,
Illinois, USA). Sensitivity analyses will be performed
to test the robustness of the results for changing se-
veral parameters, as well as subgroup analyses. In ad-
dition, current policy costs and effects of the Short
Stay programme will be compared to policy costs and
effects as calculated in the primary implementation
study, and potential differences will be related to sus-
tainability issues when applicable.
Research question three: Which are the
determinants of sustainability as perceived by the
professionals of the Short Stay Programme in breastcancer surgery and the Enhanced Recovery After
Surgery programme in colonic surgery?
Respondents
Professionals
Professionals within the participating hospitals will be
interviewed. The first interview will be conducted with
the responsible surgeon. Following this interview ap-
proximately 1-2 key persons in the actual care process
per hospital will be selected. The number of interviews
may differ per hospital based on the qualitative research
process. Before the start of the interview, the intervie-
wees will be formally informed about the relevance,
expected duration, confidentiality of the personal data
and the permission to audio tape the interviews.
External change agents
External change agents involved in the primary imple-
mentation strategies will also be invited for an interview
to explore their perspective on sustainability in relation
to the implementation processes and results.
Variables and measurements
The interview schedule (Additional file 3) for the semi
structured interviews was developed based on a list of
relevant topics inspired by the Consolidated Framework
Implementation Research (CFIR) model, recently de-
veloped by Damschroder et al [30]. The CFIR model
(Figure 1) is composed of 39 factors. These factors are
organised into five constructs: the characteristics of the
innovation, individuals involved, inner setting, outer set-
ting and the implementation process [31-34]. Further-
more, the interview will be guided by information
regarding current process and outcomes of care in com-
parison to historical results following primary imple-
mentation. The interviews will be held by one of the
researchers (either SA or FG), who were not involved
in the primary implementation process. First, after a
short introduction the interviewees’ perception of sus-
tainability in their hospital will be questioned. Second,
hospital-specific information regarding current practice
in comparison to historical results following primary im-
plementation will be graphically displayed, and intervie-
wees will be asked to reflect on these results. Third,
interviewees will be questioned about the innovation it-
self, hospital culture, incentives and other factors pos-
sibly influencing sustainability. The interviews will be
audio taped for documentation and analysis to guarantee
transparency. Interviews will take about forty-five mi-
nutes. Immediately afterwards the researcher will make
field notes. Summaries of the main findings per tran-














































Figure 1 CFIR-Model: Damschroder et al, 2009.
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The interviews will be transcribed and independently
coded by both researchers (SA and FG). Differences in
coding will be discussed until consensus is reached. Re-
search software NVivo will be used to analyse the data
and progress in coding and analysis will be discussed in
the research team.
Discussion
This paper describes the protocol of a mixed methods
observational study to gain more insight into the con-
cept of sustainability and its determinants. Two health-
care innovations were implemented in a selection of
Dutch hospitals three to five years ago, using different
implementation strategies. A Short Stay Programme was
implemented in breast cancer surgery in 4 early adopter
hospitals by means of a hospital tailored implementation
strategy, and the Enhanced Recovery After Surgery pro-
gramme in colonic surgery was implemented in 33 hos-
pitals by means of a generic implementation strategy. As
a result of these efforts, both cases showed improved
short-term results in terms of hospital length of stay.
Currently, it is unclear to what extent these innovative
programmes and their results have been sustained. In
the current study, the extent of consolidation of the
implemented programmes will be assessed in fourteen
hospitals in the Netherlands; four hospitals will partici-
pate in the breast cancer surgery case and ten hospitals
will participate in the colonic surgery case.
Strengths and limitations of the study
This study will specifically and systematically address the
sustainability of two healthcare innovations three to five
years following two different implementation strategies.
Regarding the breast cancer case, research on sustainabil-
ity is not limited to long term effects of the implementa-
tion strategy, but also comprises policy cost-effectiveness.
In the primary study, a policy cost effectiveness analysison the Short Stay Programme was performed. As a conse-
quence of e.g. changes in programme elements or case-
mix, the current cost-effectiveness may be different. A
recalculation of the cost-effectiveness will be conducted
which will partly be based on the detailed cost- and effec-
tiveness data collected during the primary study.
Another strength is the possibility to explore perceived
determinants of sustainability from two different imple-
mentation strategies. Both programmes have been im-
plemented in a multidisciplinary hospital setting. By
studying these two different programmes, a large pool of
medical specialists as well as other professionals can
be approached. As such, this study will offer a multi-
disciplinary perspective on sustainability and its determi-
nants. We have chosen for the Consolidated Framework
Implementation Research (CFIR) model to examine the
determinants and the concept of sustainability. This
framework is based on several scientific theories and
existing models and considers a wide scope of possible
determinants of sustainability.
In this study a mixed method approach will be applied,
combining quantitative data with qualitative data. In the
quantitative analyses we will examine whether the imple-
mentation results have been sustained, while in the
qualitative analyses we will examine the professionals
view on possible determinants of sustainability. The de-
terminants of sustainability will be explored by means of
semi-structured interviews with stakeholders of the
healthcare processes and external change agents. This
study is not aimed to analyse independent determinants
in a quantitative manner by means of a multivariate re-
gression model because we currently lack well-defined
hypotheses on what are the most important determi-
nants of sustainability. In this study we therefore also
chose for qualitative methods.
Furthermore, the outcome and care process data will
be extracted from patient files. The practical advantage
is that the participating professionals are not claimed for
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ord forms (CRFs). Also, by auditing the files of the last 40
breast cancer patients operated, and of the last 30 colonic
surgery patients, a Hawthorne effect will be prevented.
This is the phenomenon that a team is improving its per-
formance due to awareness of being monitored.
This study has also some limitations. The generalis-
ability of our quantitative results regarding sustainability
will be limited due to the hospital selection. An analysis
of sustainability of the ERAS programme in colonic
surgery including all 33 participating implementation
hospitals would have been optimal. Although the ten
hospitals were selected based on carefully chosen cri-
teria, it cannot be ruled out that some of the other hos-
pitals that initially were not successful in achieving the
ERAS goals, continued their activities and ultimately
implemented the protocol successfully. The evaluation
of the effects of the Short Stay Programme in breast can-
cer surgery after implementation will be conducted among
the same hospitals as during the primary study. However,
these early adopter hospitals may not fully represent
Dutch practice regarding breast cancer surgery.
The analysis of sustainability is based on extracting
data from existing data files. Although a Hawthorne effect
is thus prevented, a potential limitation is that some data
of interest for this study may not be properly recorded.
Not much is known about long term effects of imple-
mentation strategies and the determinants of sustainabil-
ity. In this study, we perform an analysis on sustainability
and we will try to shed light on potentially relevant attri-
butes of sustainable change. We will build on previous
work and aim to expand the knowledge regarding sustai-
nability and its determinants. The results of this study
will be relevant for researchers, implementation experts,
healthcare practitioners and policy makers when making
decisions about implementation and sustainability re-
source allocation.Additional files
Additional file 1: Short Stay Programme in breast cancer surgery.
Additional file 2: Enhanced Recovery After Surgery programme in
colonic surgery.
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